The Council of Scientific and Industrial Research (CSIR) is merging ancient healing traditions with modern science. Through its Lucknow-based laboratories, CSIR has developed 13 new herbal medicines aimed at tackling chronic diseases. These include treatments for diabetes, fatty liver disease, and cancer.
The initiative was highlighted at a two-day conclave held at the National Botanical Research Institute (NBRI), Lucknow. Scientists, policymakers, and industry leaders gathered to discuss how herbal medicine research can benefit patients and farmers alike.
BGR-34: A Breakthrough for Diabetes
Among the 13 medicines, BGR-34 stands out. This drug was jointly developed by NBRI and CIMAP using six medicinal herbs: Daruharidra, Giloy, Vijaysar, Gudmar, Manjistha, and Methi.
BGR-34 does more than control blood sugar. Experts suggest it may also help with diabetes reversal over time. This represents a significant step forward, as most existing medicines focus only on managing sugar levels.
Dr. Sanchit Sharma, Executive Director of Emami Pharmaceuticals, explained, “The world is now focusing on diabetes reversal. Formulations like BGR-34, which combine Ayurveda with modern science, can shape a diabetes-free society in the future.”
Herbal Solutions for Cancer and Liver Diseases
The herbal innovations also extend to cancer and liver diseases. CSIR has developed a drug based on Arjun bark (Paclitaxel) for blood cancer. For fatty liver and liver cancer, a medicine called Picroliv has been formulated.
Both drugs offer patients safer alternatives with fewer side effects. The integration of herbal components with scientific validation ensures better outcomes for chronic conditions.
Government Support for Herbal Research
Union Science and Technology Minister Dr. Jitendra Singh addressed the conclave. He praised CSIR’s achievement, calling it an example of “Lab to Society.”
He emphasized that such innovations demonstrate how research can directly benefit citizens. Singh urged startups to take herbal drugs to the international market and make Indian formulations globally competitive.
Uttar Pradesh Chief Minister Yogi Adityanath also attended the event. He inspected the exhibition, interacted with scientists, and encouraged them to continue advancing herbal research.
Startups Driving Market Reach
A major highlight of the conclave was how government laboratories are collaborating with startups. These startups act as bridges, ensuring that laboratory-developed drugs reach patients safely and effectively.
This model of research-industry partnership not only strengthens India’s healthcare ecosystem but also opens new business opportunities in the booming herbal sector.
Rising Global Demand for Natural Remedies
The event comes at a time when global demand for natural and herbal treatments is rising sharply. Consumers are increasingly seeking safe, side-effect-free alternatives to conventional medicine.
India, with its strong foundation in Ayurveda and herbal traditions, has a unique opportunity. Experts believe scientifically validated herbal medicines from India can lead global healthcare in the coming years.
Dr. Sanchit Sharma added, “This is not just medicine. It’s a model of science and tradition that could influence the global healthcare agenda.”
Research on Medicinal Plants
Institutes like NBRI and CIMAP are also focusing on improving the quality of medicinal plants. By developing advanced plant varieties, they can help farmers achieve higher yields and better income.
This dual benefit—enhancing farmer livelihoods and providing affordable herbal medicines—strengthens the vision of sustainable healthcare and agriculture.
BGR-34 and the Global Diabetes Challenge
Globally, diabetes remains one of the most pressing health issues. Current treatments often involve lifelong medication. The promise of BGR-34 lies in its potential for reversal, not just control.
If proven effective on a global scale, BGR-34 could revolutionize diabetes management. Its herbal origins also make it attractive for markets seeking natural solutions.
The Role of CSIR in Integrating Ayurveda and Science
CSIR’s approach combines traditional knowledge with modern scientific validation. This integration ensures that herbal remedies are not just cultural practices but scientifically proven treatments.
This model provides India with credibility in both domestic and international markets. It also reflects the government’s commitment to promoting innovation rooted in Indian traditions.
Farmers as Key Stakeholders
The expansion of herbal medicine research directly benefits farmers. With demand rising for medicinal plants like Giloy, Methi, and Arjun bark, farmers can diversify their crops and secure higher incomes.
This alignment between healthcare and agriculture ensures that the herbal medicine movement supports both public health and rural development.
International Market Potential
India’s herbal formulations are already gaining recognition globally. With proper clinical trials and certifications, products like BGR-34 and Picroliv can become part of international treatment protocols.
Startups have a crucial role in packaging, branding, and exporting these medicines. If supported by government initiatives, India could emerge as a world leader in herbal therapeutics.
Challenges and Future Prospects
While the progress is promising, challenges remain. Large-scale clinical validation, international regulatory approvals, and consumer awareness are key hurdles. However, with strong government backing and rising consumer demand, the prospects look bright.
By 2030, India’s herbal medicine industry could reach billions in global exports, positioning the country as a hub for natural healthcare solutions.
Conclusion: A Herbal Healthcare Revolution
The development of 13 new herbal medicines by CSIR marks a turning point in Indian healthcare. From diabetes reversal with BGR-34 to cancer treatments using Arjun bark, these innovations highlight the strength of combining Ayurveda and modern science.
The involvement of startups ensures these formulations reach patients effectively. Farmers benefit through improved crop demand, while patients gain affordable, safe, and side-effect-free medicines.
With growing global interest in natural remedies, India stands at the forefront of a herbal healthcare revolution. As Union Minister Jitendra Singh said, this is a shining example of “From Lab to Society”—science directly improving human lives.
